November 11, 2016
Nearly 16,000 bottles of Ramipril Capsules, USP, 1.25 mg, have been recalled, as reported in the latest US Food and Drug Administration (FDA) Enforcement Report.
The ongoing, Class III recall involves 30-count bottles of the prescription angiotensin-converting enzyme inhibitor that were distributed throughout the United States and Puerto Rico.
So why the recall? Bottles from lot # 1136091A were labeled with the incorrect expiration date of 03/18 instead of the correct date of 09/17, according to the report.
Actavis Laboratories FL Inc. initiated the recall on August 30, and the FDA gave it a Class III designation on November 1.
—Meredith Edwards White